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Background-Most studies showed that Helicobacterpylori(HP) infection increased the rate of 
gastric mucosal proliferation and apoptosis. Non-steroidal antHnflammatory drugs (NSAIDs) 
is also known to affect epoptosis of gastric epithelial cells, but there is little information about 
interaction between Hp infection and NSAIDs administration. Aim-The aim of this study is to 
investigate the dynamic balance between apoptosis and proliferation and genetic changes in 
subjects started on aspirin. Methods-serial biopsy specimens of the gastric antrum were 
obtained during endoscopy from 12 Hp positive subjects with eradication, 12 Hp positive 
subjects without eradication and 12 Hp negative subjects, all of whom were started on 100 
mg of aspirin at time O. Apoptosis and proliferation were measured by TUNEL and PCI~ 
immunostaining. The expression of apoptosis associated proteins bel-2, bax, and CPP-32 
was also detected by immunohistocbemical staining. Results-The apoptotic index (AI)was 
significantly increased in Hp positive patients without eradication after six month (from 
12.17±3.83 to 17.58±7.82, P<O.05); whereas there was no significant changes in Hp positive 
patients 6 months after eradication and in Hp negative patients. Similarly there ware significant 
increase in proliferation index (PI) and the ratio of AI/PI only in Hp posiUve subjects without 
eradication, accompanied by a marked increase in expression of apo~otic protein bax. The 
expression of bcl-2 and CPP32 remained unchanged in all groups. Conclusions-These results 
suggest that active Hp infection and aspirin intake increase apoptosis and proliferation of 
gastric epithelial cells, and upset the AI/PI balance. The additive effect is blocked by treatment 
of Hp. This may provide a molecular basis for eradication of Hp before initiation of acpidn treat- 
ment. 
3036 
Development of an Improved Formulation of PhosphaUdyicholine (PC) - Associated 
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) 
Lenard M, Lichtenberger, Jimmy J. Romero, Univ of Texas Medical Sch, Houston, 13(; 
Sudershan K. Sanduja, Natural Therapeutics Inc, Sugar Land, TX 
Backgound: We have previously reported that: the gastric mucosa has hydrophobic harrier 
properties due to the presence of PC and other zwltterionic pbospholipids within and coating 
the overlying mucus gel layer; and that NSAIDs have an ability to weaken this lining by 
chemically associating with PC (Nature Mud 1:154,1995). Accordingly. we have developed a 
strategy to prevent this interaction,and as a consequence NSAID-induced topical injury, by 
pre-associating an NSAID with either purified or synthetic PC. Earlier pre-clinical and clinical 
studies demonstrated that aqueous suspensions of a number of PC-NSAIDs have both lower 
GI toxicity and enhanced therapeutic activity in comparison to the unmodified drugs (Nature 
Mud; Am J Castro 94:1818, 1999; JPET 277:2773,1996). In the present study we evaluated 
a new method to prepare PC-NSAIDs that has the advantage that the final formulation is 
both solid and cost-effective. Methods: PC-NSAIDs were prepared by admixing a lecithin oil 
containing 35% PC with one of the following NSAIDs: aspirin (ASA); iboprofen (IBU); or 
indomethacin (INDO), until a uniform paste was formed. These solid formulations were then 
tested in acute rodent models of: ASA-induced gastric ulceration; IBU- and INDO - induced 
GI bleeding; and NSAID-induoed analgesic ac~vity (RandalI-Sellifo,Arch lot ~ 111: 
409, 1957). Results: It was demonstrated that gastric ulceration was significantly reduced by 
70.3±3.5% by PC-ASA, and GI bleeding was significantly reduced by 42.3±6.4% and 
82.0±8.5% by PC-IBU and PC-INDO respectively, in comparison to the values of rats adminis- 
tered the unmodified drugs.Consistent with these observations employing acute models of 
NSAID-induced injury, we also determined that PC-INDO induced less diarrhea and significantly 
fewer intestinal lesions and adhesions than unmodified INDO during a 4 day treatrneof period. 
The increased GI safety of the new PC-NSAID formulations was not attributable to a lower 
bioavallability of the NSAIDs when administered as a solid, as the analgesic activity of PC- 
ASA, PC-IBU and PC-INDO were all significantly enhanced in comparison to the unmodified 
drugs. Conclusion: These results indicate that the new cost-effective method to formulate 
PC-NSAIDs provides a GI safe, therapeutically superior product to treat chronic inflammatory 
disorders. Long-term clinical trials evaluating the GI safety of this new family of PC-NSAIDs 
are planned. (supported by NIH grants DK 53195 and DK 52740) 
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Background. Prostaglandins (PGs) derived from the inducible cyclooxigenase COX-2, play an 
important role in gastric ulcer healing. The question is, whether the new NSAID, which inhibit 
predominantly COX-2, are really safe in the long-term use in conditions of a previously 
established chronic ulcer. Aim. To asses the different healing process and PGs levels, leukocyte 
infiltration and COX expression, using classical NSAID, in comparison with the new selective 
COX-2 inhibitor celecoxib (CLX), 0.35 mg/Kg, Materials and Methods. A chronic ulcer was 
induced in rats by injection of 5% acetic acid into the gastric sutiserosa. Animals were treated 
twice daily (i.g.) during 8 and 14 days with following: vehicle, piroxicam (PRX), 0.35 mg/Kg, 
metamizol (MET), 33 mg/Kg, and CI.X, 1.8 mg/Kg. Macroscopic ulcer index (Ul), myeloperoxi- 
dace activity (MPO) as an index of neutrophil infiltration and PGE2 content, were measured 
at the ulcer site as well as in mucosa around the ulcer crater. Histology and immunoreactivity 
for COX-1 and COX-2 were also studied. Results. All NSAID delayed ulcer healing, although 
there where no significant differences in UI. MPO was significantly higher at the ulcer site 
than in the intact mucosa after treatments (p<O.O01). PRX significantly increased MPO activity 
at the ulcer site vs sham and control (p<O.01). On the contrary CLX decreased the enzymatic 
activity (p<O.05). PGE~ content increased significantly at the ulcer site (p<O.01) vs intact 
mucosa of the ulcerated control. All NSAID suppressed FGE2 generation in ulcerated and non- 
ulcerated tissues. Histological examination showed no important differences between both 
drugs but confirmed high neutrophil infiltration in case of PRX. COX-1 was expressed predomi- 
nantly in the neck region and bottom of gastric glands and there were not any differences 
between groups. COX-2 was expressed mainly in regions of maximal repair activity at the 
ulcer base and superficial mucous cells and mucous cells of the foveoles. COX-2 expression 
was markedly stronger with PRX and control than which CLX. Conclusions. Selective and 
non-selective NSAID delay ulcer healing, wich may be related with a descent in PGE2 content 
and different behaviour in COX-1 and COX-2 expression. Inflammatory responses in case of 
PRX may be also implicated. 
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BACKGROUND: Gastric mucosa was peroxidized during NSAID-induced gastric mucosal 
lesions formation, Recently, a monoclonal antibody for a tissue protein reacted with 4- 
hydroxynononal (4HNE) has become available, which can indicate distribution of tissue peroxi- 
dation. Using this monoclonal antibody, we have previously reported that the deep part of 
the gastric mucoSa is particularly peroxidized following NSAID treatment. The parietal cells 
which are particularly located in the deep part of the gastric mucosa, consume great amount 
of oxygen when they produce gastric juice. This high oxygen consumption may lead to 
enhanced production of oxygen radicals and thus increased tissue peroxidizatidn in the deep 
part of gastric mucosa, but this possibility has not been tested at all. AIM: We thus aimed 
to elucidate the relationship between tissue peroxidation and acid secretion after the NSAID 
treatment. For this purpose, we investigated whether the pretreatment with rabeprazole, one 
of a p ro~  pump inhibitor (PPI), affected the 4HNE generation induced by NSAID treatment 
or not. METHODS: Male Wistar rats were divided into the following 4 groups: 1) control 
group, 2) indomethacin group, 3) rabeprazole group, 4) rabeprazole and indomethacin group. 
Each rat in both the indomathacin group and the rabeprazole and iodomethacin group was 
administered 30 mgrkg indomethacin per us after 24 hours fasting. Rats in both the rabeprazola 
group and the rabeprazole and indomethacin group was pretreated 30 rain before the indometh- 
acin administration with 10 mg/kg rabeprazole. Each rat stomach was removed at either O, 
15, 30, 60, 180 or 300 mio alter the NSAID treatment. These cryosections of these stomachs 
were immunohistochamically stained with both anti-4HNE antibody and anti-8(OH)dG antibody. 
RESULTS: 4HNE began to appear in the deep layer of the gastric mucosa at 30 rain after the 
indomefhacin treatment. The area of 4HNE time-sequentially extended to the surface layer. 
The formation of 8(OH)dG appeared from 180 rain after the treatment in the same area as 
4HNE. The pretreatment with rabeprazole significantly inhibited 4HNE generation and 8(OH)dG 
formation. CONCLUSION: The indomethacin treatment induced tissue peroxidation as well as 
ONA injury, eapec~ly in the deep part of, the gastric mucoca. The pretreatment with PPI 
significantly inhibited the NSAID treatment-induced tissue peroxidation. These results suggest 
that gas~ acid secretion accelerates tissue peroxidation in gastric mucosa. 
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BACKGROUND/OBJECTIVES: Gastrointestinal damage is the major limitation to the use 
NSAIOs. Nitric oxide (NO) is a mediator of gastrointestinal mucosal defence, but it also 
contributed to mucosel injury in some circumstances. The role of NO in the NSAID-gastmintesti- 
nal damage was not defined. We investigated the effect of inhibitors of both inducible and 
constitutive NOS on the gastric damage (GD) induced by different doses of indomethacin 
(INDO). MATERIAL AND METHODS: GD was induced by intragastric instilation of INDO (2.5; 
5; 20 and 40mg/Kg) and assessed 1, 3, 6, 12, 24 hs later. A lesion index (LI) was calculated 
as the sum of the lengths of all lesions. Different groups, received dexamethasone (lmg/Kg), 
L-NAME (lOOmg/Kg), N-Nitro-arginine (lOOmg/Kg), aminoguanidine (lOOmg/Kg), L-Arginine 
(1000mg/Kg), D-Arginine (lO00mg/Kg) or L-Lisine (lO00mg/Kg). After 1 hour, GD was induced 
by INDO (5 or 20mg/Kg) and 3 hs later the animals were killed and LI was calculated. 
RESULTS: INDO caused a significant and dose- dependent GD with maximal effect at a dose 
of 20 mg/Kg (p<O.O01). GD peaked at 3 hs after injection of INDO (5 or 20mg/Kg) and 
returned to control levels at the end of 24 hs. Pretreatment with dexamethasone 
(LI = 12.0±5.2mm; N = 10), L-NAME (LI = 12.7±3.6mm; N = 10), N-Nitro-Arginine 
(LI= 12.3±6.3mm; N=IO), Aminoguanide (LI =11.3±5.3mm; N=fO), or L-Arginine 
(Ll=6.0±3.1mm; N=IO) but not D-Arginine (Ll=21.4±6.1mmn; N= 7) or L-Lisine 
(Ll=29.4-+ll.5mm; N=5) significantly inhibited (P<O.05) the INDO 20 mg/Kg induced 
damage (Ll=30.2±4.8mm; N=16). In contrast, GD induced by INDO 5mg/Kg 
(Ll=7.8±2.2mm; N=15) tended to increase by pretreatment by both L-NAME 
(LI = 11.4_+3.2mm; N = 15) and N-Nitro-arginine (LI = 17-4.6mm; N = 9), but the differences 
did not attain statistical significance (p= 0,2 and p=g,36), whereas the pretreatment with 
L-Arginine plus L-NAME (LI = 1.4 ±0.1 mm; N = 10) reduced significantly (p<O.05) GD induced 
by INO0 5mg/Kg with L-NAME (11.4±3.2mm; N =15). Aminoguanidine had no effect 
(LI =6.5±2.2mm; N=5), whereas L-Arginine (LI = 5.3±2.1mm; N =10), but not D-Arginine 
(LI = 11.7_+5.5mm; N = 5), tended to reduce GD induced by iNDO 5mg/Kg (LI = 7.3±2.2mm; 
N=15). CONCLUSIONS 1-NOS inhibitors had a different effects depending on the dose of 
the INO0. 2- The pretreatment with NOS substrate as well as inhibitors impaired gastric 
damage induced by INDO 20 mg/Kg. 3- The effect of L-Argine seems may be specific, since 
because D-Arginine and L-lisine do not cause it. Financial support = FAPESP, PRONEX. 
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